AIM ImmunoTech Inc. (AIM)
Largest Insider Buys in Sector
AIM Stock Price History Chart
AIM Stock Performance
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic …
Insider Activity of AIM ImmunoTech Inc.
Over the last 12 months, insiders at AIM ImmunoTech Inc. have bought $142,677 and sold $0 worth of AIM ImmunoTech Inc. stock.
On average, over the past 5 years, insiders at AIM ImmunoTech Inc. have bought $108,295 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Equels Thomas K (CEO & President) — $72,676. APPELROUTH STEWART (director) — $30,000. Rodino Peter W III (COO, Secretary, Gen. Counsel) — $25,000.
The last purchase of 5,000 shares for transaction amount of $1,515 was made by Equels Thomas K (CEO & President) on 2024‑09‑16.
List of Insider Buy and Sell Transactions, AIM ImmunoTech Inc.
| 2024-09-16 | CEO & President | 5,000 0.0089% | $0.30 | $1,515 | -12.79% | |||
| 2024-09-13 | CEO & President | 20,000 0.0363% | $0.31 | $6,160 | -12.77% | |||
| 2024-05-06 | CEO & President | 61,729 0.117% | $0.41 | $25,000 | -16.71% | |||
| 2024-05-06 | COO, Secretary, Gen. Counsel | 30,865 0.0585% | $0.41 | $12,500 | -16.71% | |||
| 2024-03-21 | director | 38,462 0.0806% | $0.39 | $15,000 | -4.24% | |||
| 2024-03-15 | CEO & President | 75,758 0.1551% | $0.33 | $25,000 | +12.28% | |||
| 2024-03-15 | director | 90,910 0.1861% | $0.33 | $30,000 | +12.28% | |||
| 2024-03-15 | COO, Secretary, Gen. Counsel | 37,879 0.0776% | $0.33 | $12,500 | +12.28% | |||
| 2023-11-27 | CEO & President | 33,861 0.0699% | $0.44 | $15,000 | -6.79% | |||
| 2023-09-29 | CEO & President | 22,676 0.0452% | $0.44 | $10,000 | -6.80% | |||
| 2023-08-25 | CEO & President | 8,222 0.0169% | $0.67 | $5,501 | -34.28% | |||
| 2023-08-24 | CEO & President | 14,993 0.0308% | $0.67 | $10,000 | -35.27% | |||
| 2023-07-17 | CEO & President | 16,950 0.0334% | $0.59 | $10,001 | -27.42% | |||
| 2023-01-03 | CEO & President | 161,291 0.3212% | $0.31 | $50,000 | +54.75% | |||
| 2023-01-03 | director | 80,646 0.1606% | $0.31 | $25,000 | +54.75% | |||
| 2023-01-03 | COO, Secretary, Gen. Counsel | 80,646 0.1606% | $0.31 | $25,000 | +54.75% | |||
| 2021-07-16 | CEO & President | 15,625 0.0317% | $1.92 | $30,000 | -45.96% | |||
| 2021-02-25 | director | 10,638 0.0233% | $2.35 | $24,999 | -14.89% | |||
| 2021-02-24 | CEO & President | 11,062 0.0233% | $2.26 | $25,000 | -14.89% | |||
| 2020-12-17 | CEO | 14,535 0.042% | $1.72 | $25,000 | +9.63% |
Insider Historical Profitability
| Equels Thomas K | CEO & President | 1493042 2.3436% | $0.22 | 40 | 0 | <0.0001% |
| APPELROUTH STEWART | director | 239765 0.3764% | $0.22 | 8 | 0 | <0.0001% |
| Rodino Peter W III | COO, Secretary, Gen. Counsel | 212583 0.3337% | $0.22 | 5 | 0 | <0.0001% |
| BRYAN NANCY | director | 38462 0.0604% | $0.22 | 1 | 0 | |
| CARTER WILLIAM A | CEO | 1225585 1.9238% | $0.22 | 12 | 3 |
Institutional Investor Ownership
| The Vanguard Group | $936,680.00 | 3.48 | 1.99M | 0% | +$0 | <0.0001 | |
| BlackRock | $328,915.00 | 1.22 | 698,333 | -1.34% | -$4,461.78 | <0.0001 | |
| Geode Capital Management | $165,689.00 | 0.62 | 351,657 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $104,000.00 | 0.39 | 220,808 | +9.31% | +$8,854.75 | <0.0001 | |
| State Street | $81,532.00 | 0.3 | 173,103 | 0% | +$0 | <0.0001 |